{"vid":"V539","name":"comments","file_id":"F4","var_intrvl":"discrete","var_width":"155","labl":"General comments","var_sumstat":[{"value":"692","type":"vald"}],"var_catgry":[{"value":"5-10%  has history of blood pressure  started on HCTZ 25mg OD","labl":null,"stats":"1","type":"freq"},{"value":"5-10% - RISK PREDICTION","labl":null,"stats":"1","type":"freq"},{"value":"5-10%- LOW RISK PREDICTION","labl":null,"stats":"1","type":"freq"},{"value":"<5% RISK PREDICTION","labl":null,"stats":"1","type":"freq"},{"value":"> 30%","labl":null,"stats":"1","type":"freq"},{"value":">10-20% stage I","labl":null,"stats":"1","type":"freq"},{"value":">30% RISK PREDICTION","labl":null,"stats":"1","type":"freq"},{"value":"ADVICE TO VISIT THE KARIOBANGI CLINIC","labl":null,"stats":"1","type":"freq"},{"value":"ADVICED ON CUTTING DOWN WEIGHT","labl":null,"stats":"1","type":"freq"},{"value":"ADVICED ON LIFESTYLE CHANGE RISK PREDICTION >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"ADVICED ON LIFESTYLE MODIFICATION","labl":null,"stats":"1","type":"freq"},{"value":"ADVICED ON WEIGHT REDUCTION","labl":null,"stats":"1","type":"freq"},{"value":"ADVICED TO CONTINUE COLLECTING INSULIN AT KARIOBANGI","labl":null,"stats":"1","type":"freq"},{"value":"AGE 62 YRS. RISK PREDICTION >20%","labl":null,"stats":"1","type":"freq"},{"value":"AGE 63 WAS ON HCTZ  CT HCTZ","labl":null,"stats":"1","type":"freq"},{"value":"AGE GREATER THAN OR EQUAL TO60  YEARS, RISK PREDICTION - MODERATE >10-20%. KNOWN ASTHMATIC. SYSTOLIC >160","labl":null,"stats":"1","type":"freq"},{"value":"AGE NOT IN THE CHART","labl":null,"stats":"1","type":"freq"},{"value":"Advised on lifestyle change .  Risk predicton moderate >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"CLIENT FOLLOWED UP AT KNH FOR DM AND HYPERTENSION. SHE PREFERS TO CONTINUE TREATMENT FOR THE SAME AT KENYATTA. SHE HAS NO PROBLEM WITH TREATMENT COST.","labl":null,"stats":"1","type":"freq"},{"value":"CLIENT WENT HOME TO BRING THE PREMEDICATION DRUGS BUT THE CLINIC WAS CLOSED BEFORE HE RETURNED","labl":null,"stats":"1","type":"freq"},{"value":"COMPLAINS OF HEADACHE AND DIZZINESS","labl":null,"stats":"1","type":"freq"},{"value":"D.O.B  during independence???  Risk prediction>10-20%  Stage 2 HTW.","labl":null,"stats":"1","type":"freq"},{"value":"DIABETIC","labl":null,"stats":"2","type":"freq"},{"value":"Dm only:  Also known asthmatic.","labl":null,"stats":"1","type":"freq"},{"value":"FASTING BLOOD SUGAR 9.2","labl":null,"stats":"1","type":"freq"},{"value":"HAS HISTORY OF BLOOD PRESSURE. ON NIFEDIPINE 20MG, ENALAPRIL 5MG  RISK PREDICTION 5-10%","labl":null,"stats":"1","type":"freq"},{"value":"HIGH  >20-20%","labl":null,"stats":"1","type":"freq"},{"value":"HIGH >30%","labl":null,"stats":"1","type":"freq"},{"value":"HIGH >30% II HYPERTENSION","labl":null,"stats":"1","type":"freq"},{"value":"HIGH PREDICTION  > 30%","labl":null,"stats":"1","type":"freq"},{"value":"HIGH PREDICTION  >30%","labl":null,"stats":"1","type":"freq"},{"value":"HIGH PREDICTION >30%","labl":null,"stats":"2","type":"freq"},{"value":"HIGH RISK >20-20%","labl":null,"stats":"1","type":"freq"},{"value":"HIGH RISK >30%","labl":null,"stats":"1","type":"freq"},{"value":"HIGH RISK PREDICTION 20-20%","labl":null,"stats":"1","type":"freq"},{"value":"HIGH RISK PREDICTION >30%","labl":null,"stats":"3","type":"freq"},{"value":"HTN STAGE II  RISK PREDICTION >20-20%","labl":null,"stats":"1","type":"freq"},{"value":"HYPER TENSION STAGE II RISK PREDICTION MODERATE >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"HYPERTENSION STAGE II >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"HYPERTENSION STAGE II RISK PREDICTION-MODERATE","labl":null,"stats":"1","type":"freq"},{"value":"HYPERTENSIVE STAGE II RISK PREDICTION LOW 5-10%, BEGIN MEDS","labl":null,"stats":"1","type":"freq"},{"value":"High prediction > 20-20%","labl":null,"stats":"1","type":"freq"},{"value":"High, greater than 30%","labl":null,"stats":"1","type":"freq"},{"value":"II HYPERTENSIVE","labl":null,"stats":"1","type":"freq"},{"value":"Know diabetic, measured from Hospice","labl":null,"stats":"1","type":"freq"},{"value":"LOW <5%","labl":null,"stats":"1","type":"freq"},{"value":"LOW PREDICTION  5-10%","labl":null,"stats":"1","type":"freq"},{"value":"LOW PREDICTION 5-10%","labl":null,"stats":"1","type":"freq"},{"value":"LOW PREDICTION <5%","labl":null,"stats":"1","type":"freq"},{"value":"LOW RISK <5-10% + DIABETIC","labl":null,"stats":"1","type":"freq"},{"value":"LOW RISK<5%","labl":null,"stats":"1","type":"freq"},{"value":"MODERATE  >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"MODERATE >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"MODERATE PREDICTION    >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"MODERATE PREDICTION 10-20%","labl":null,"stats":"1","type":"freq"},{"value":"MODERATE PREDICTION > 10-20%","labl":null,"stats":"1","type":"freq"},{"value":"MODERATE PREDICTION >10-20%","labl":null,"stats":"5","type":"freq"},{"value":"MODERATE PREDICTION: 10-20%","labl":null,"stats":"1","type":"freq"},{"value":"MODERATE PREDITION >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"MODERATE RISK PREDICTION","labl":null,"stats":"1","type":"freq"},{"value":"MODERATE RISK PREDICTION >10-20%","labl":null,"stats":"2","type":"freq"},{"value":"MODERATE>10-20%","labl":null,"stats":"1","type":"freq"},{"value":"MONITOR BLOOD GLUCOSE. FBS RECOMMENDED NEXT VISIT.  RISK PREDICTION HIGH >30%","labl":null,"stats":"1","type":"freq"},{"value":"NO DRUGS","labl":null,"stats":"1","type":"freq"},{"value":"NO DRUGS ISSUED","labl":null,"stats":"1","type":"freq"},{"value":"NON SMOKER,TAKES ALCOHOL.RISK PREDICTION LOW <5%.hYPERTENSIVE STAGE II","labl":null,"stats":"1","type":"freq"},{"value":"NONE","labl":null,"stats":"1","type":"freq"},{"value":"NONE HYPERTENSIVE FOR REVIEW ON 3\/11\/2012. RISK PREDICTION 5-10%","labl":null,"stats":"1","type":"freq"},{"value":"No chart","labl":null,"stats":"1","type":"freq"},{"value":"No chart;","labl":null,"stats":"1","type":"freq"},{"value":"PATIENTS HAS DRUGS FOR 1\/12 WAS SEEN AT ST MARYS LANGATA. RISK >20-20% BUT ON STAGE  REVIEW 1\/12","labl":null,"stats":"1","type":"freq"},{"value":"REFERRED TO CONTINUE WITH KARIOBANGI CLINIC","labl":null,"stats":"1","type":"freq"},{"value":"RISK 10-20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK 10-20% DIETARY CONTROL\/ BEHAVIORAL CONTROL","labl":null,"stats":"1","type":"freq"},{"value":"RISK 20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK 20% HAS BEEN ON ENALAPRIL","labl":null,"stats":"1","type":"freq"},{"value":"RISK 20% LIFESTYLE & HCTZ","labl":null,"stats":"1","type":"freq"},{"value":"RISK 30% ON RX","labl":null,"stats":"1","type":"freq"},{"value":"RISK 5-10%","labl":null,"stats":"1","type":"freq"},{"value":"RISK 5-10%  LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK 5-10%  PT HAS BEEN ON  HTN ENALAPRIL,HCTZ","labl":null,"stats":"1","type":"freq"},{"value":"RISK 5-10% LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK 5-10% LOW LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK 5-10% ON ANTI HTN   LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK 5-10% STAGE 1LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK <5% LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK > 10-20%  PT IS ON ENALAPRIL, HCTZ AND METFOEMIN","labl":null,"stats":"1","type":"freq"},{"value":"RISK >10-20%  STAGE I HTN","labl":null,"stats":"1","type":"freq"},{"value":"RISK >10-20% STAGE I","labl":null,"stats":"1","type":"freq"},{"value":"RISK >10-20% STAGE I HTN LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK >20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK >20%  DIABETIC N HTN","labl":null,"stats":"1","type":"freq"},{"value":"RISK >20-20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK >30%","labl":null,"stats":"4","type":"freq"},{"value":"RISK >30% STAGE II","labl":null,"stats":"1","type":"freq"},{"value":"RISK ABOVE 30%","labl":null,"stats":"1","type":"freq"},{"value":"RISK FACTOR >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK FACTOR HIGH >20-30%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PRDICCTION <5%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICION >30%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION","labl":null,"stats":"6","type":"freq"},{"value":"RISK PREDICTION   10-20%  STAGE I HTN","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION   10-20%  STAGE II HTN","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION   >10-20%","labl":null,"stats":"5","type":"freq"},{"value":"RISK PREDICTION   >10-20%  LIFESTYLE CHANGE WITH REVIEW AFTER 3MONTH","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION   >10-20%  MODERATE","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION   >20%","labl":null,"stats":"3","type":"freq"},{"value":"RISK PREDICTION   >5%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION   >5%. STAGE I HTN","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION   MODERATE  >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION  5 \u2013 10%  NO DRUGS","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION  5-10% STAGE I HTN LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION  >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION  >20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION  HIGH >20-20%  HTN STAGE II","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION - <5%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION - >10-20% (MODERATE)","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION - LOW <5%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION - NOT POSSIBLE BECAUSE OF THE AGE 84YEARS","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION ->10-20% NO DRUGS ISSUED","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 10-20%  LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 10-20%  STAGE I HYPERTENSION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 10-20% LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 10-20%. START LIFESTYLE MODIFICATION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 20-20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 5%-10%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 5-10%","labl":null,"stats":"22","type":"freq"},{"value":"RISK PREDICTION 5-10%  LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 5-10%  NO DRUGS ISSUED","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 5-10%  STAGE I HTN","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 5-10%  STAGE I HTN   PLAN LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 5-10%  STARTED ON TREATMENT  ADVICED ON LIFESTYLE CHANGE","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 5-10% CLIENT HAS NO COMPLAIN RELATED TO DM","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 5-10% STAGE HTN LIFESTYLE ADJ","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 5-10% STAGE I HTN LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 5-10% STAGE II HTN LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION 5-10%, (HTN STAGE II)","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION < 5%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION <20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION <5  NO DRUGS ISSUED","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION <5%","labl":null,"stats":"29","type":"freq"},{"value":"RISK PREDICTION <5%  NO DRUGS","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION <5%  NO DRUGS ISSUED","labl":null,"stats":"6","type":"freq"},{"value":"RISK PREDICTION <5%  NO DRUGS ISSUEID","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION <5% REQUEST FIRST TO CONTINUE WITH LIFESTYLE","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION <5%. HTN STAGE I","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION <5%. HTN STAGE II","labl":null,"stats":"3","type":"freq"},{"value":"RISK PREDICTION > 10- 20%","labl":null,"stats":"2","type":"freq"},{"value":"RISK PREDICTION > 10-20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION > 20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION > 30%","labl":null,"stats":"3","type":"freq"},{"value":"RISK PREDICTION >10% -20% (MODERATE). CLIENT HAS  BEEN ON LASIX. CLIENT SUFFERED STROKE 2010 DEC","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10%-20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10%-20%  NO DRUGS ISSUED","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10%-20% (MODERATE)  NO DRUGS ISSUED","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10%-20% NO DRUGS ISSUED","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10-20%","labl":null,"stats":"23","type":"freq"},{"value":"RISK PREDICTION >10-20%  NO DRUGS","labl":null,"stats":"3","type":"freq"},{"value":"RISK PREDICTION >10-20%  NO DRUGS ISSUED","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10-20%  STAGE II HTN","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10-20%  STAGE II HYPERTENSION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10-20% ADVISED ON LIFESTYLE","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10-20% MODERATE","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10-20% NO DRUGS","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10-20% NO DRUGS ISSUED","labl":null,"stats":"3","type":"freq"},{"value":"RISK PREDICTION >10-20% STAGE I HTN  LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10-20% STAGE I HTN LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10-20%. HTN STAGE 2","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >10-20%. STAGE II","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >20%","labl":null,"stats":"10","type":"freq"},{"value":"RISK PREDICTION >20%  ADVICED TO COME WITH OTHER MEDICATION SHE IS TAKING DURING THE NEXT VISIT","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >20%  AGE IS 70 YEARS","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >20%  ENCOURAGED TO BRING THE DRUGS SHE IS ON IN NEXT VISIT OF 03\/10\/12","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >20% DIABETIC","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >20% STAGE I HTN","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >20-20%","labl":null,"stats":"11","type":"freq"},{"value":"RISK PREDICTION >20-20% HTN II","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >20-20% KNOWN HYPERTENSIVE AND ON NIFEDIPINE","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >20-20%,  PATIENT IS 83YEARS OLD","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >30%","labl":null,"stats":"32","type":"freq"},{"value":"RISK PREDICTION >30%  PT IS ON HYPERTENSIVES","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >30%  STAGE II HTN","labl":null,"stats":"2","type":"freq"},{"value":"RISK PREDICTION >30%  STAGE II HYPERTENSION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >30% HTN STAGE II","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >30% STAGE II HTN","labl":null,"stats":"2","type":"freq"},{"value":"RISK PREDICTION >30%. BEGIN MEDS AND LIFESTYLE MODIFICATION. MONITOR RBS CLOSELY","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION >5%","labl":null,"stats":"4","type":"freq"},{"value":"RISK PREDICTION >5-10%","labl":null,"stats":"3","type":"freq"},{"value":"RISK PREDICTION ABOVE 30%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION ABOVE CHART ESTIMATE PLAN START HCTZ STAGE II HTN","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION HIGH","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION HIGH (20-30%). BEGIN MEDS + LIFESTYLE MODIFICATION, REVIEW AFTER ONE MONTH","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION HIGH 20-20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION HIGH 20-30%. STAGE I HYPERTENSION. START LIFESTYLE MODIFICATION + MEDS","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION HIGH 20-30%. START MEDS + LIFESTYLE MODIFICATION. FOR FBS NEXT VISIT","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION HIGH > 20% IN STAGE II HYPERTENSION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION HIGH >20% STAGE I HYPERTENSION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION HIGH >20-20%","labl":null,"stats":"2","type":"freq"},{"value":"RISK PREDICTION HIGH >20-30%","labl":null,"stats":"2","type":"freq"},{"value":"RISK PREDICTION HIGH >20-30%  STAGE I HYPERTENSION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION HIGH >20-30%. START LIFESTYLE MODIFICATION + MEDS. MONITOR RBG CLOSELY IF NO CHANGE ADD METFORMIN","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION HIGH >30%","labl":null,"stats":"5","type":"freq"},{"value":"RISK PREDICTION HIGH >30%. STAGE I HYPERTENSION. START MEDS","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION LOW  5-10%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION LOW 5-10%","labl":null,"stats":"4","type":"freq"},{"value":"RISK PREDICTION LOW 5-10%. BEGIN LIFESTYLE MODIFICATION. REVIEW AFTER 1MONTH","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION LOW 5-10%. NOT ENROLLED SHE IS BELOW 35YRS.","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION LOW 5-10%. NOT ENROLLED SHE'S BELOW 35YRS","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION LOW 5-10%. TO BEGIN LIFESTYLE MODIFICATION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION LOW <5%","labl":null,"stats":"3","type":"freq"},{"value":"RISK PREDICTION LOW <5%. BEGIN LIFESTYLE MODIFICATION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION LOW <5%. CT LIFESTYLE  MODIFIDICATION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION LOW <5-10%,ADVICED ON LIFESTYLE MODIFICATION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION LOW<5%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION MODERATE 10-20%","labl":null,"stats":"2","type":"freq"},{"value":"RISK PREDICTION MODERATE 10-20%  STAGE II HYPERTENSION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION MODERATE 10-20%.  WITH ISOLATED SYSTOLIC HYPERTEENSION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION MODERATE 10-20%. CT ANTIDIABETICS","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION MODERATE 10-20%. MONITOR BP CLOSELY IFNO CHANGE AFTER 3 MONTHS START MEDS. TARGET BP IN DM IS <130\/80mmHg","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION MODERATE 10-20%. STAGE I HYPERTENSION.","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION MODERATE 10-20%. STAGE I HYPERTENSION. START LIFESTYLE MODIFICATION.","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION MODERATE 10-20%. STAGE II HYPERTENSION.","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION MODERATE 5-10%. START LIFESTYLE MODIFICATION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION MODERATE <10-20%. BEGIN LIFESTYLE MODIFICATION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION MODERATE >10-20%","labl":null,"stats":"8","type":"freq"},{"value":"RISK PREDICTION MODERATE >10-20% ADVICE ON LIFESTYLE ADJUSTMENT AND MONTHLY FOLLOWUP","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION MODERATE >10-20%. START LIFESTYLE MODIFICATION","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION MOODERATE >10_20% NO DRUGS ISSUED","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION \u2013 LOW 5 -10% HYPERTENSION 2nd DEGREE TO THYROTOXICOSIS","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION: MODERATE 5-10%  ADVISED ON LIFESTYLE ADJUSTMENT & ADHERENCE COUNSELLING","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION<5%","labl":null,"stats":"2","type":"freq"},{"value":"RISK PREDICTION>10-20%","labl":null,"stats":"2","type":"freq"},{"value":"RISK PREDICTION>20%","labl":null,"stats":"4","type":"freq"},{"value":"RISK PREDICTION>30%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTION>30%  STAGE II HTN","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREDICTON >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK PREEDICTION 5-10%","labl":null,"stats":"1","type":"freq"},{"value":"RISK REDICTION >20-20%","labl":null,"stats":"1","type":"freq"},{"value":"RISK> 20% HCTZ 25mg OD*32\/7","labl":null,"stats":"1","type":"freq"},{"value":"Risk  prediction  >30%","labl":null,"stats":"1","type":"freq"},{"value":"Risk > 20-20%","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction  mod  >10-20%  HTM TWO.","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction - >10% -20% (MODERATE) NO DRUGS ISSUED.","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction 20-30%.","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction 5%","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction 5-10%","labl":null,"stats":"2","type":"freq"},{"value":"Risk prediction 5-10%  Stage 1 hypertension","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction > 10-20%","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction > 10-20%  but patient was on meds before","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction >10-20%.  No drugs  issued.","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction >20%,    Age 80 years,  Cannot stand no measurements.","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction >5% lifestyle adjustment.","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction greater than 10-20%","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction high>20-30.  start meds +lifesytle modification.","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction less than 5%","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction low  25% in stage II hypertension.","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction low (5-10).  start lifesytle modification.","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction low 25%","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction low 5-10%","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction low <5-10%  a follow -up kariobangi;","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction low<5%  stage 1 hypertension","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction not able to calculate. Due to his age and BP 140, recommend to start Rx","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction- loe 5-10%  Advised on lifesytle modification.","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction.  >-20%.","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction<5%(low).","labl":null,"stats":"1","type":"freq"},{"value":"Risk prediction>30%.","labl":null,"stats":"1","type":"freq"},{"value":"SATGE II HYPERTENSION","labl":null,"stats":"3","type":"freq"},{"value":"SATGE II HYPERTENSION  PATIENT REPORTED TO HAVE A HEART LESION BUT ABSCONDED CLINIC AT KNH  NB: HIP AND WAIST MEASURES NOT TAKEN. SHE WAS NOT ABLE TO STAND","labl":null,"stats":"1","type":"freq"},{"value":"SEVERE HYPERTENSION - HEADACHE  BLURRED VISION AGE-60 YEARS","labl":null,"stats":"1","type":"freq"},{"value":"SMOKER  RISK PREDICTION >30%","labl":null,"stats":"1","type":"freq"},{"value":"STAGE 2 HYPERTENSION","labl":null,"stats":"1","type":"freq"},{"value":"STAGE I HYPERTENSION   RISK PREDICTION LOW 5-10%  START ON NIFEDIPINE  REFFERED TO KARIOBANGI FOR FOLLOW UP","labl":null,"stats":"1","type":"freq"},{"value":"STAGE I HYPERTENSION  RISK PREDICTION >30%  START MEDS + LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"STAGE I HYPERTENSION  RISK PREDICTION >30%`","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION","labl":null,"stats":"52","type":"freq"},{"value":"STAGE II HYPERTENSION   NB: RESPONDENT CANNOT STAND BY HIS FEET","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION   RISK PREDICTION HIGH 20-30%  START ANTIHYPERTENSIVE + LIFESTYLE MODIFICATION","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION  NB: PATIENT UNABLE TO STAND","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION  PREVIOUSLY SUFFERED NIFEDIPINE SIDE EFFECTS  EFFECTS OF OEDEMA","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION  RISK 20% ALLERGIC TO ENALAPRIL (DRY COUGH)","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION  STARTED RX ON 21\/11\/2012","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION  TABS NIFEDIPINE 40MG START  CHECK BP 171\/81","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION + DIABETES","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION AND DIABETIES","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION PLAIN LIFESTYLE ADJUSTMENT","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION SEPARATED","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION. CLIENT HAS NO HTN EMERGENCY SIGNS","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION. RISK PREDICTION HIGH >20% LIFESTYLE MODIFICATION + MEDS","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSION.CLIENT DIDNT COME WITH DRUGS SHE IS ON SHE PREFERS TO CONTINUE WITH DRUGS SHE IS ON","labl":null,"stats":"1","type":"freq"},{"value":"STAGE II HYPERTENSIVE","labl":null,"stats":"1","type":"freq"},{"value":"START MEDS. RISK PREDICTION HIGH 20-30%; BUT TARGET BP OK","labl":null,"stats":"1","type":"freq"},{"value":"She has a histroy of hypertension  Continue monitoring her BP","labl":null,"stats":"1","type":"freq"},{"value":"Stage I hypertension  risk prediction greater than 20%","labl":null,"stats":"1","type":"freq"},{"value":"Stage II Hypertension.","labl":null,"stats":"1","type":"freq"},{"value":"Stage II hypertension","labl":null,"stats":"31","type":"freq"},{"value":"Stage II hypertension. Risk greater than 20-26%","labl":null,"stats":"1","type":"freq"},{"value":"Start RX Risk factor high due to age and BD   NB\/Respodent cannot stand.","labl":null,"stats":"1","type":"freq"},{"value":"To a Kariobangi clinic.","labl":null,"stats":"1","type":"freq"},{"value":"To be seen on 5th\/4 for fashing blood sugar.","labl":null,"stats":"1","type":"freq"},{"value":"bp was too high could not be measured by BP machine","labl":null,"stats":"1","type":"freq"},{"value":"continue follow -up  kARIOBANGI","labl":null,"stats":"1","type":"freq"},{"value":"hypertensive stage II  risk prediction - moderate greater than 10-20%","labl":null,"stats":"1","type":"freq"},{"value":"low 5-10%","labl":null,"stats":"1","type":"freq"},{"value":"low less than 5%  advised on lifestyle  advised on change F\/P method visit FP clinic","labl":null,"stats":"1","type":"freq"},{"value":"low prediction 5-10%","labl":null,"stats":"1","type":"freq"},{"value":"moderase     >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"moderate prediction 10-20%","labl":null,"stats":"1","type":"freq"},{"value":"moderate risk greater than 10-20%","labl":null,"stats":"1","type":"freq"},{"value":"moderate risk prediction","labl":null,"stats":"1","type":"freq"},{"value":"on follow-up at Kariobangi, to continue.","labl":null,"stats":"1","type":"freq"},{"value":"risk 10-20%  lifestyle","labl":null,"stats":"1","type":"freq"},{"value":"risk 10-20%  lifestyle adjustment","labl":null,"stats":"1","type":"freq"},{"value":"risk 20%","labl":null,"stats":"1","type":"freq"},{"value":"risk 20%  lifestyle and HCTZ","labl":null,"stats":"2","type":"freq"},{"value":"risk 30%","labl":null,"stats":"1","type":"freq"},{"value":"risk 5-10%","labl":null,"stats":"1","type":"freq"},{"value":"risk 5-10%  lifestyle adjustment","labl":null,"stats":"1","type":"freq"},{"value":"risk predcition > 30%","labl":null,"stats":"1","type":"freq"},{"value":"risk predcition less than 5%","labl":null,"stats":"1","type":"freq"},{"value":"risk predcition less than 5%  no drugs issued","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction (no chart)  RBG reads high","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction - moderate, greater than 10-20%","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction - moderate,> 10-20%  advised on lifestyle modification","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction 10-20%","labl":null,"stats":"2","type":"freq"},{"value":"risk prediction 10-20%  stage II HTN   lifestyle","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction 20-20%","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction 5-10%","labl":null,"stats":"15","type":"freq"},{"value":"risk prediction 5-10%  HTN Stage II","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction 5-10%  no drugs","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction 5-10%  no drugs issued","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction 5-10% STG I HTN","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction 5-10% low","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction <5%","labl":null,"stats":"6","type":"freq"},{"value":"risk prediction > 10-20%","labl":null,"stats":"2","type":"freq"},{"value":"risk prediction > 20%","labl":null,"stats":"3","type":"freq"},{"value":"risk prediction >10-20%","labl":null,"stats":"6","type":"freq"},{"value":"risk prediction >20-20%","labl":null,"stats":"2","type":"freq"},{"value":"risk prediction >20-20%  hypertension stage II","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction >30%","labl":null,"stats":"3","type":"freq"},{"value":"risk prediction >30%  hypertension stage II","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction >30%  patient is 75years old","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction >5% stage I HTN","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction >5-10%","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction greater than 10-20%","labl":null,"stats":"2","type":"freq"},{"value":"risk prediction greater than 20%","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction greater than 20-20%","labl":null,"stats":"2","type":"freq"},{"value":"risk prediction greater then 20-20%  low BMI","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction high 20-30%  continue all meds","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction high >  30%","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction high > 30%  Advised on lifestyle modification, meanwhile to start oral hypoglycaemics","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction high >30%","labl":null,"stats":"2","type":"freq"},{"value":"risk prediction less than 5%","labl":null,"stats":"4","type":"freq"},{"value":"risk prediction low 5-10%","labl":null,"stats":"3","type":"freq"},{"value":"risk prediction low 5-10%  stage II hypertension","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction low < 5%","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction low <5%","labl":null,"stats":"2","type":"freq"},{"value":"risk prediction low <5%  hypertension stage II","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction low <5%  stage II hypertension","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction moderate 10-20%","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction moderate 20-20%","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction moderate 20-30%  stage I hypertension","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction moderate >10%-20%","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction- low: >5%","labl":null,"stats":"1","type":"freq"},{"value":"risk prediction-low 5-10%.","labl":null,"stats":"1","type":"freq"},{"value":"risk predictions 5-10%","labl":null,"stats":"1","type":"freq"},{"value":"riskprediction >10-20%","labl":null,"stats":"1","type":"freq"},{"value":"stage II HYPERTENSION","labl":null,"stats":"1","type":"freq"},{"value":"stage II hyoertension","labl":null,"stats":"1","type":"freq"},{"value":"stage II hypertension","labl":null,"stats":"8","type":"freq"},{"value":"stage II hypertension. risk prediction low 5%","labl":null,"stats":"1","type":"freq"}],"var_format":"character","var_format_schema":"other","fid":"F4","sid":"79","survey_idno":"APHRC-SCALEUP-2014-1.0"}